Skip to main content
. 2019 Jul 16;11(7):992. doi: 10.3390/cancers11070992
LAPC locally advanced prostate cancer
SFCs sphere-forming cells
EMT epithelial-mesenchymal transition
TIL tumor-infiltrating lymphocytes
MDSC myeloid-derived suppressor cells
CSCs Cancer stem cells
CRPC castration-resistant prostate cancer
ADT androgen deprivation therapy